All data are based on the daily closing price as of April 2, 2025
c

Center Laboratories

4123.TWO
1.15 USD
0.01
+0.88%

Overview

Last close
1.15 usd
Market cap
827.26M usd
52 week high
1.74 usd
52 week low
1.10 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
16.832
Price/Book Value
1.5143
Enterprise Value
924.49M usd
EV/Revenue
18.937
EV/EBITDA
-13.4142

Key financials

Revenue TTM
48.82M usd
Gross Profit TTM
22.60M usd
EBITDA TTM
11.56M usd
Earnings per Share
-0.05 usd
Dividend
0.02 usd
Total assets
778.88M usd
Net debt
154.68M usd

About

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising of antipyretic and analgesic, bronchodilator, anti-inflammatory preparations, anti-allergic agent, expectorant, narcotic antitussive and expectorant, gastrointestinal preparations, non-narcotic antitussive and expectorant, and other medicines. It also offers central nervous system medication consisting of cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and parkinson's disease, as well as provides treatment for diabetes and pancreatic beta cells. In addition, the company engages in drug development, cell therapy, biotechnology, biopharmaceutical, hydrogen energy, and dairy business. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei City, Taiwan.
  • Symbol
    4123.TWO
  • Exchange
    TWO
  • Isin
    TW0004123005
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Ms. Su-Chi Wang
  • Headquarter
    Taipei City
  • Web site
    https://www.centerlab.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top